ESSA Pharma (EPIX) Stock Statistics & Valuation Metrics

ESSA Pharma has a market cap or net worth of $70.13M. The enterprise value is $142.43M.

ESSA Pharma has 44.39M shares outstanding. The number of shares has decreased by -2.65% in one year.

ESSA Pharma’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is ―.

The current PE Ratio of ESSA Pharma is 0.00. ESSA Pharma’s PEG ratio is 0.00.

In the last 12 months, ESSA Pharma had revenue of $0.00 and earned -$31.11M in profits. Earnings per share was -$0.69.

In the last 12 months, operating cash flow was -$22.47M and capital expenditures $0.00, giving a free cash flow of -$22.47M billion.

ESSA Pharma pays an annual dividend of , resulting in a dividend yield of

ESSA Pharma upcoming earnings date is May 13, 2025, TBA.

ESSA Pharma as a current ratio of 38.64, with Debt / Equity ratio of <0.01

In the past 12 months, ESSA Pharma has paid $20.27K in taxes.

ESSA Pharma EV to EBITDA ratio is 0.00, with an EV/FCF ratio of -7.26.

ESSA Pharma has $120.45M in cash and marketable securities with $305.04K in debt, giving a net cash position of -$120.15M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for ESSA Pharma is $2.25, which is 11.43% higher than the current price. The consensus rating is Hold